Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · Real-Time Price · USD
3.840
+0.040 (1.05%)
At close: Nov 21, 2024, 4:00 PM
3.976
+0.136 (3.54%)
After-hours: Nov 21, 2024, 5:06 PM EST

Revance Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
58.59137.33108.97110.62333.56171.16
Upgrade
Short-Term Investments
125.49116.59231.74114.45102.95118.96
Upgrade
Cash & Short-Term Investments
184.08253.92340.71225.07436.51290.12
Upgrade
Cash Growth
-38.69%-25.47%51.38%-48.44%50.46%65.01%
Upgrade
Accounts Receivable
48.2627.6811.343.351.86-
Upgrade
Receivables
48.2627.6811.343.351.86-
Upgrade
Inventory
85.2145.5818.3310.155.88-
Upgrade
Prepaid Expenses
9.9411.154.367.545.766.49
Upgrade
Restricted Cash
0.470.55----
Upgrade
Other Current Assets
1.74-----
Upgrade
Total Current Assets
329.69338.87374.73246.12450296.6
Upgrade
Property, Plant & Equipment
76.9990.2159.426947.1341.29
Upgrade
Goodwill
--77.18146.96146.96-
Upgrade
Other Intangible Assets
7.639.8135.3455.3371.34-
Upgrade
Long-Term Accounts Receivable
----0.08-
Upgrade
Other Long-Term Assets
47.2539.5735.2413.754.72.4
Upgrade
Total Assets
461.56478.45581.9531.16720.22340.29
Upgrade
Accounts Payable
12.3413.814.5510.612.668.01
Upgrade
Accrued Expenses
32.852.9159.3637.6629.6717.43
Upgrade
Current Portion of Long-Term Debt
10.152.5----
Upgrade
Current Portion of Leases
17.218.354.914.754.443.47
Upgrade
Current Unearned Revenue
6.3310.746.879.367.857.91
Upgrade
Other Current Liabilities
1.220.92-4.926.354.16
Upgrade
Total Current Liabilities
80.0589.2275.6867.2960.9640.98
Upgrade
Long-Term Debt
421.04426.6379.37280.64180.53-
Upgrade
Long-Term Leases
35.0440.9934.1839.1327.1525.87
Upgrade
Long-Term Unearned Revenue
85.5570.4278.5874.1577.2947.95
Upgrade
Other Long-Term Liabilities
2.912.841.491.49--
Upgrade
Total Liabilities
624.59630.06569.3462.69345.93114.8
Upgrade
Common Stock
0.110.090.080.070.070.05
Upgrade
Additional Paid-In Capital
2,0441,9271,7671,4661,5011,070
Upgrade
Retained Earnings
-2,207-2,078-1,754-1,398-1,126-844.2
Upgrade
Comprehensive Income & Other
0.070.01-0.37-0.02-0
Upgrade
Total Common Equity
-163.03-151.612.668.47374.29225.49
Upgrade
Shareholders' Equity
-163.03-151.612.668.47374.29225.49
Upgrade
Total Liabilities & Equity
461.56478.45581.9531.16720.22340.29
Upgrade
Total Debt
483.45478.43418.47324.51212.1129.34
Upgrade
Net Cash (Debt)
-299.37-224.52-77.76-99.44224.4260.78
Upgrade
Net Cash Growth
-----13.95%48.33%
Upgrade
Net Cash Per Share
-3.09-2.65-1.07-1.473.876.00
Upgrade
Filing Date Shares Outstanding
104.988.2182.871.4571.3856.93
Upgrade
Total Common Shares Outstanding
104.987.9682.3971.5869.1852.37
Upgrade
Working Capital
249.64249.64299.05178.83389.04255.62
Upgrade
Book Value Per Share
-1.55-1.720.150.965.414.31
Upgrade
Tangible Book Value
-170.66-161.41-99.92-133.83155.98225.49
Upgrade
Tangible Book Value Per Share
-1.63-1.84-1.21-1.872.254.31
Upgrade
Machinery
---25.7323.1221.82
Upgrade
Construction In Progress
---3.111.542.39
Upgrade
Leasehold Improvements
---7.485.975.37
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.